Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: ADVAIR HFA

« Back to Dashboard

Summary for Tradename: ADVAIR HFA

Patents:18
Applicants:1
NDAs:1
Suppliers: see list1

Clinical Trials for: ADVAIR HFA

A Study In Pediatric Subjects With Asthma Using ADVAIR HFA, ADVAIR HFA With Spacer, And ADVAIR DISKUS
Status: Completed Condition: Asthma

Onset of Action of Advair Hydrofluoroalkane (HFA) 115/21 in Comparison to Symbicort Pressurised Metered-Dose Inhalers (pMDI) 160/4.5 Measured by Impulse Oscillometry (IOS)
Status: Recruiting Condition: Asthma

MGR001 / Advair Diskus Local Equivalence Study in Asthma
Status: Recruiting Condition: Asthma

The Effect on Depressive Symptoms in ECF Residents With COPD
Status: Completed Condition: Chronic Obstructive Pulmonary Disease; Depression

The Impact of Salmeterol-Fluticasone on Sleep in Patients With COPD
Status: Withdrawn Condition: Chronic Obstructive Pulmonary Disease; Sleep Disorders

Special Drug Use Investigation for ADOAIR DISKUS COPD (Salmeterol and Fluticasone)
Status: Completed Condition: Pulmonary Disease, Chronic Obstructive

Atlantis Symbicort
Status: Completed Condition: Asthma

Strategy for Early Treatment of Exacerbations in COPD: Standing Prescriptions of Advair With a Written Action Plan in the Event of an Exacerbation
Status: Completed Condition: COPD; Chronic Obstructive Pulmonary Disease

Comparing Fluticasone-Salmeterol in Chronic Obstructive Pulmonary Disease (COPD) and Sleep
Status: Not yet recruiting Condition: COPD

Dose-Response of Salmeterol in Children
Status: Completed Condition: Asthma

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxo Grp Ltd
ADVAIR HFA
fluticasone propionate; salmeterol xinafoate
AEROSOL, METERED;INHALATION021254Jun 8, 2006RXYes6,743,413*PED<disabled>Y<disabled>
Glaxo Grp Ltd
ADVAIR HFA
fluticasone propionate; salmeterol xinafoate
AEROSOL, METERED;INHALATION021254Jun 8, 2006RXYes6,435,372*PED<disabled>Y<disabled>
Glaxo Grp Ltd
ADVAIR HFA
fluticasone propionate; salmeterol xinafoate
AEROSOL, METERED;INHALATION021254Jun 8, 2006RXYes6,510,969*PED<disabled>Y<disabled>
Glaxo Grp Ltd
ADVAIR HFA
fluticasone propionate; salmeterol xinafoate
AEROSOL, METERED;INHALATION021254Jun 8, 2006RXYes6,997,349*PED<disabled>Y<disabled>
Glaxo Grp Ltd
ADVAIR HFA
fluticasone propionate; salmeterol xinafoate
AEROSOL, METERED;INHALATION021254Jun 8, 2006RXYes5,658,549*PED<disabled>Y<disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc